Results 171 to 180 of about 19,675 (219)

Nationwide trends of balloon pulmonary angioplasty and pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension (2012-2019). [PDF]

Pulm Circ
Vohra AS, Olonoff DA, Ip A, Kirtane AJ, Steinberg Z, Horn E, Krishnan U, Reisman M, Bergman G, Wong SC, Feldman DN, Kim LK, Singh HS.   +12 more
europepmc   +1 more source

Angiographic classification of total occlusion and its implication on balloon pulmonary angioplasty. [PDF]

ESC Heart Fail
Yang T, Li X, Luo Q, Zhao Q, Zeng Q, Zhang Y, Duan A, Huang Z, Hu M, Zhang S, Gao L, Xiong C, Zhao Z, Liu Z.   +13 more
europepmc   +1 more source

Cardiothoracic Imaging for Outcome Prediction in Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Endarterectomy or Balloon Pulmonary Angioplasty: A Scoping Review. [PDF]

J Clin Med
Malik M, Malik S, Karur GR, Mafeld S, de Perrot M, McInnis MC.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension

Journal of Vascular and Interventional Radiology, 2019
Chronic thromboembolic pulmonary hypertension (CTEPH) is classified as Group-4 pulmonary hypertension caused by organized thrombi in pulmonary arteries. Pulmonary endarterectomy (PEA) has been shown to improve the symptoms and prognoses of patients with proximal CTEPH.
Sreeja, Sanampudi, Sonja, Bartolome, Sanjeeva, Kalva   +2 more
  +7 more sources

Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension

Cardiovascular Intervention and Therapeutics, 2021
Chronic thromboembolic pulmonary hypertension (CTEPH) is caused by chronic stenosis or obstruction of the pulmonary arteries due to thromboembolism. Although previous studies have shown untreated CTEPH has a poor prognosis, the establishment of gold-standard therapies including pulmonary endarterectomy, balloon pulmonary angioplasty (BPA), and medical ...
Kyoko, Hirakawa, Eiichiro, Yamamoto, Seiji, Takashio, Shinsuke, Hanatani, Satoshi, Araki, Satoru, Suzuki, Koichi, Kaikita, Kenichi, Matsushita, Takeshi, Ogo, Kenichi, Tsujita   +9 more
openaire   +2 more sources

Management of Complications of Balloon Pulmonary Angioplasty

Interventional Cardiology Clinics, 2023
Since the publication of the first case series reporting the outcomes of patients with chronic thromboembolic pulmonary hypertension who underwent treatment with balloon pulmonary angioplasty more than 30 years ago, significant improvements to the procedural technique have made balloon pulmonary angioplasty (BPA) a safe and effective therapy that we ...
Amine, Nasri, Riyaz, Bashir, Vladimir, Lakhter   +2 more
openaire   +2 more sources

Balloon pulmonary angioplasty in inoperable chronic thromboembolic pulmonary hypertension

BMJ Case Reports, 2022
Balloon pulmonary angioplasty (BPA) is an emerging treatment for inoperable chronic thromboembolic pulmonary hypertension (CTEPH) or residual/recurrent pulmonary hypertension after pulmonary thromboendarterectomy. We report two patients with inoperable and severe CTEPH who were submitted to the BPA programme after optimised treatment with long-term ...
Pereira, Ana Rita, Calé, Rita, Ferreira, Filipa, Pereira, Helder   +3 more
openaire   +3 more sources

Balloon Pulmonary Angioplasty

2017
Balloon pulmonary angioplasty (BPA) is a promising treatment option for patients with chronic thromboembolic pulmonary hypertension who are considered ineligible for surgical treatment. Since 2012, the effect of balloon pulmonary angioplasty has been reported mainly in Japan, but currently, it is attracting the attention of many pulmonary hypertension ...
Hiromi Matsubara, Aiko Ogawa
openaire   +1 more source